about
Definition of treatment goals for moderate to severe psoriasis: a European consensusEvolving pattern of drug-induced toxic epidermal necrolysis.Evidence- and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis - International League of Dermatological Societies in cooperation with the European Dermatology Forum - Short version.Chitosan Coated Textiles May Improve Atopic Dermatitis Severity by Modulating Skin Staphylococcal Profile: A Randomized Controlled TrialOcular involvement in toxic epidermal necrolysis.Euromelanoma: a dermatology-led European campaign against nonmelanoma skin cancer and cutaneous melanoma. Past, present and future.Spanish-Portuguese consensus statement on use of daylight-mediated photodynamic therapy with methyl aminolevulinate in the treatment of actinic keratosis."Retronychia--clinical and pathophysiological aspects".Gangrene of the fingertips after bleomycin and methotrexate.Filaggrin Polymorphism Pro478Ser Is Associated With the Severity of Atopic Dermatitis and Colonization by Staphylococcal aureus.Multiple minute digitate hyperkeratosis affecting the face and folds: clinical, dermoscopic, and histological report of a familial case.The Euromelanoma skin cancer prevention campaign in Europe: characteristics and results of 2009 and 2010.Are General Physicians Prepared for Struggling Skin Cancer?-Cross-Sectional Study.Cutaneous mastocytosis: Two pediatric cases treated with topical pimecrolimus.Bullous fixed drug eruption to etoricoxib--further evidence of intraepidermal CD8+ T cell involvement.Possible phototoxicity with subsequent progression to discoid lupus following pantoprazole administration.Multiple eccrine hidrocystomas--from diagnosis to treatment: the role of dermatoscopy and botulinum toxin.Nail melanoma in situ: clinical, dermoscopic, pathologic clues, and steps for minimally invasive treatment.Giant subungual glomus tumor: clinical, dermoscopy, imagiologic and surgery details.Risk of Stevens-Johnson syndrome and toxic epider mal necrolysis during first weeks of antiepileptic therapy: a case-control studySunbed use among Portuguese beach goers: a crave group while waiting sunbeds to be abolishedGenital fixed drug eruption: cross-reactivity between doxycycline and minocyclineNail Changes Secondary to Docetaxel (Taxotere)[Lyell's syndrome and griseofulvin]Airborne contact dermatitis from the woods Acacia melanoxylon and Entandophragma cylindricumCutaneous T-cell recruitment in toxic epidermal necrolysis. Further evidence of CD8+ lymphocyte involvementBullous photodermatosis after lomefloxacinAcute exanthematous pustular dermatitis after pneumococcal vaccineHIV-1 in blister fluid of a patient with toxic epidermal necrolysis and AIDSIncreased interleukin 10, tumor necrosis factor alpha, and interleukin 6 levels in blister fluid of toxic epidermal necrolysisNasal tip metastasis revealing a Pancoast tumourCD8+ lymphocytes in the blister fluid of severe acute cutaneous graft-versus-host disease: further similarities with toxic epidermal necrolysisSoluble interleukin 2 receptor and interleukin 1alpha in toxic epidermal necrolysis: a comparative analysis of serum and blister fluid samplesAdverse effect of a nutritional supplement for hair loss[Atopic dermatitis, innate immunity, and infection]
P50
Q24604445-FC873BA7-CEF2-4F61-8773-8D429379F616Q34061746-3B441364-A694-4270-85B4-D770660D452EQ35775164-396501E7-5BDF-4DEB-9E8D-13C673276F68Q35855543-FAB877EA-AD77-4E68-B1C9-7F729F50CB03Q38028982-CEA328F3-0BFA-473E-99C5-9249F98B0A9AQ38033616-5AB08188-1857-48A0-BD9B-62A0EC24D61FQ38538740-D1D453C9-BEE2-418B-A6A2-F5FDD022DD18Q38598997-F9BCA122-1ECC-4FDB-965B-0253B6E25B81Q39553757-9A7AEA77-8BAB-4669-BDF7-26F33260E9ECQ40742118-14252AC6-6514-47C6-A307-BA2ADCAD0D46Q41666161-EE4DB0B1-B5A1-477F-8D16-ECD32007EBDFQ42495084-78B9B0C1-8F80-49AB-9790-A9B48FD80E98Q42496100-DBDF3863-BC33-4303-A283-050907E49694Q43056900-DD742214-5758-4A14-B7B6-3BB6AF524A6FQ43181574-1D7E7BA6-D255-469D-9552-E561B5CB7648Q43697991-B1835ADC-3AB8-4407-A05E-641D375E9BC3Q47866563-1CD1B3D8-664E-4B1A-A7A8-4D75DF7EFC55Q49028041-E3FC8145-229E-410B-8A05-5A91BF193E66Q50205962-3E8EEB52-2D01-434D-9CEF-29AB896DA305Q57244516-4B6E5384-6845-4BB6-A03A-657D79E8EFEDQ57569758-2B24D2B9-5D5F-4EDE-95CD-1B95F086032DQ61460200-7725DB8B-7053-4C58-B05E-1B8EA68BCF07Q61460206-153170AD-D31D-425D-90C2-1A2A8D0701EAQ67787299-7FD415B1-E31D-468D-983E-FC2D7141E420Q68002952-6D8D4DD8-2288-43DF-A17F-1E5A461D0E11Q70643094-382819E0-329C-4EB7-A7B1-BCEB729B4EB4Q71992393-0A2D1657-A80D-455D-A9FB-B429DA7497C3Q72554367-4F560B44-A82D-4F97-B1DA-344BC5058787Q72824676-B39EC95E-DF2F-47D8-A411-F3FD5F132FE5Q74336122-F70D7B11-8943-431A-883B-961FCD43354FQ74528392-14F88322-C689-4301-8F82-54C046DE0A82Q77149507-3515A1FB-CE79-4C2C-8ECD-45783EE461C9Q77486027-052A6CE3-7AD6-4FF3-ABD6-D0A81F7A79C7Q83769647-3EEDD8E6-1B88-4C65-BDB6-197B95DA4072Q84926917-42E0DE2B-677F-4AD0-BF1E-10243EF9891F
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究者
@zh
name
O Correia
@ast
O Correia
@en
O Correia
@es
O Correia
@nl
type
label
O Correia
@ast
O Correia
@en
O Correia
@es
O Correia
@nl
prefLabel
O Correia
@ast
O Correia
@en
O Correia
@es
O Correia
@nl
P31
P496
0000-0001-8666-6345